Latest technology advances to innovate drug design, discovery and development Novel automated discovery laboratory on track to open in 2023 OXFORD, England–(BUSINESS WIRE)–Exscientia plc (Nasdaq: EXAI) today announced two abstracts for oral and poster presentation, as well as the closing keynote to be delivered at the Society for Laboratory Automation and Screening (SLAS) Europe Conference … [Read more…]
SUZHOU, China–(BUSINESS WIRE)–Thousand Oaks Biologics Inc. (TOBio) and GeneQuantum Healthcare (Suzhou) Co., Ltd. (GQ) are pleased to announce that they have formed a strategic partnership focusing on the CMC development of ADC products with a core conjugation technology for more stable drug candidates. The over 200 million RMB collaboration will allow GQ to leverage TOBio’s … [Read more…]
Alcon in Action, a company-wide community volunteerism initiative, reinforces the company’s year-round commitment to community engagement and bolsters Alcon’s aspiration to improve lives and strengthen communities Thousands of company associates across 30 countries participate in the initiative that inspires associates to make direct, positive impacts in their local communities Follow the activities on Alcon Facebook, … [Read more…]
IDENTIFY PH presented at ATS WASHINGTON–(BUSINESS WIRE)–#ML—CorVista Health, Inc., a leading digital health company dedicated to improving cardiovascular disease diagnosis, announces the presentation of a machine-learned algorithm to IDENTIFY PH at the American Thoracic Society (ATS) conference. This proof of concept showcases the effectiveness of a machine learned (ML) phase space electro-mechanical pulse wave analysis … [Read more…]
UZEDY significantly reduced the risk of relapse by up to 80% and prolonged the time to impending relapse by up to 5.0 times while having a similar safety profile to other formulations of risperidone1,2 The U.S. Food and Drug Administration (FDA) approved UZEDY on April 28, 2023 for the treatment of schizophrenia in adults as … [Read more…]
Drivers from Peoria, St. Louis, Louisville, Nashville take part in 12th Annual St. Jude Corvette Drive MEMPHIS, Tenn.–(BUSINESS WIRE)–Patients, their families and employees celebrated the 12th Annual St. Jude Corvette Drive today, an epic road trip that starts in Peoria, Ill. and cruises through St. Jude Children’s Research Hospital® in Memphis before turning back. Along … [Read more…]
CHICAGO–(BUSINESS WIRE)–Exicure, Inc. (“Exicure” or the “Company”) (Nasdaq: XCUR), announced today it received a notice of non-compliance from Nasdaq Stock Market LLC (“Nasdaq”) on May 17, 2023 notifying the Company that, as a result of the Company’s failure to timely file its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2023 … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “New Drug Approvals and Their Contract Manufacture – 2023 Edition” report has been added to ResearchAndMarkets.com’s offering. In 2022, the FDA approved c100+ new drug applications (NDAs) and biologics license applications (BLAs). This figure represents a decrease over the 2017-21 period. Both small molecule and biologic new molecular entity (NME) approvals declined substantially, … [Read more…]
New manufacturing facility and expanded capabilities will enable Singapore’s science and technology sector to accelerate research, development and manufacturing of critical medicines and vaccines WALTHAM, Mass. & SINGAPORE–(BUSINESS WIRE)–Thermo Fisher Scientific, the world leader in serving science, has opened a new sterile drug facility in Singapore that will better enable customers to deliver new medicines … [Read more…]
Seven oral and poster presentations highlighted during meeting Phase 3 MARCH PFIC data selected as one of highest scoring abstracts and presented during the plenary session RISE study evaluating LIVMARLI in infants with ALGS and PFIC included among highest scoring posters FOSTER CITY, Calif.–(BUSINESS WIRE)–#alagillesyndrome–Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced data presented during the … [Read more…]
